Endo, Watson Settle Litigation Over Opana ER Generic

By Julie Zeveloff · October 7, 2010, 4:19 PM EDT

Endo Pharmaceuticals Inc. has resolved litigation against Watson Pharmaceuticals Inc. over Watson's proposed generic version of the painkiller Opana ER, with Endo granting Watson a royalty-free license to U.S. patents covering...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

PACER Docket

Recent Articles By Julie

October 13, 2010
Cobalt Released From Sepracor Suit Over Sleep Drug
October 07, 2010
Pfizer Recalls 191,000 Lipitor Bottles Due To Odor
October 05, 2010
Teva Sues Mylan, Others Over Proposed Azilect Generic
September 30, 2010
Novartis Contact Lens Patent Invalid, UK Court Affirms
September 23, 2010
US, EU Regulators Ban GSK's Avandia In Most Cases
August 11, 2010
Conceptus Falsely Marked Sterilization Kit, Rival Says
July 27, 2010
St. Jude Goes After Volcano Over Guide Wire Patents
July 26, 2010
Wyeth Bests Pa. Fen-Phen Hypertension Suit
July 16, 2010
King Pharma Sues Sandoz Over Generic EpiPen
July 15, 2010
Latham Reps Carlyle Group In $3.8B NBTY Acquisition